Next Sunday, April 20th 2025, starting 8:30am GMT, there will be maintenance work that will involve the website being unavailable during parts of the day. We apologize for any inconvenience this may cause and appreciate your understanding.
We noted you are experiencing viewing problems
-
Check with your IT department that JWPlatform, JWPlayer and Amazon AWS & CloudFront are not being blocked by your network. The relevant domains are *.jwplatform.com, *.jwpsrv.com, *.jwpcdn.com, jwpltx.com, jwpsrv.a.ssl.fastly.net, *.amazonaws.com and *.cloudfront.net. The relevant ports are 80 and 443.
-
Check the following talk links to see which ones work correctly:
Auto Mode
HTTP Progressive Download Send us your results from the above test links at access@hstalks.com and we will contact you with further advice on troubleshooting your viewing problems. -
No luck yet? More tips for troubleshooting viewing issues
-
Contact HST Support access@hstalks.com
-
Please review our troubleshooting guide for tips and advice on resolving your viewing problems.
-
For additional help, please don't hesitate to contact HST support access@hstalks.com
We hope you have enjoyed this limited-length demo
This is a limited length demo talk; you may
login or
review methods of
obtaining more access.
Printable Handouts
Navigable Slide Index
- Introduction
- Severe combined immunodeficiency
- Diseases associated with IL-7R polymorphisms
- Thymic defect in IL-7R-/- mice
- Gene therapy of SCID
- Gene therapy and cancer risk
- Gamma-c cytokine receptors
- IL7 receptor knockout
- IL7 ligand knockout
- Effect of IL-7 survival of pro-T subsets
- Bcl-2 family of anti and pro-apoptotic proteins
- Trophic factor & mitochondrial damage
- Bcl-2 promotes D1 cell survival
- Bax deficiency restores T cell development
- The effect of IL-7 withdrawal
- IL-7R mutants from human T-ALL
- Mutant hIL-7R and ligand-independent signaling
- D1 cells with mutant hIL-7R induce tumors in vivo
- Mutant IL-7R converts D1 to tumor-forming cells
- Hematopoietic neoplasm in multiple organs
- hIL-7Ralpha mutants promote dimerization
- Mutant IL-7Ralpha model
- Exon 6 of IL-7Ralpha (1)
- Exon 6 of IL-7Ralpha (2)
- Lymphocyte homeostasis
- Homeostatic correction
- Resource limitation example (1)
- Resource limitation example (2)
- Resource limitation example (3)
- Resource limitation example (4)
- Resource limitation example (5)
- Resource limitation example (6)
- IL-7 and nave CD8 homeostasis
- Classical proliferation pathway model
- IL-7/IL-3 proliferation pathway model (1)
- IL-7/IL-3 proliferation pathway model (2)
- IL-7/IL-3 proliferation pathway illustration
- Thymic cells expressing knock-in IL-7-CFP
- Class II MHC expression on thymic epithelium
- Class II MHC expression on skin dendritic cells
- Developing thymocides grow in a matrix
- Matrix nature
- Thymic epithelial cell matrix
- Looking down through the matrix
- In the embryonic thymus
- IL-7-CFP knock-in
- IL-7 in the bone marrow
- rhIL-7 increases in vivo TCR repertoire diversity
- IL-7 drives T cell-cycle entry & expansion in HIV-1
- Progressive multifocal leukoencephalopathy
- IL-7 improves survival in sepsis
- Treatment with IL-7 inhibitors
- Acknowledgments
- Producing cytokines painting
Topics Covered
- IL-7 in T cell development
- IL-7R in leukemia
- IL-7 in T cell homeostasis
- IL-7-expressing cells
Links
Series:
Categories:
Therapeutic Areas:
Talk Citation
Durum, S. (2012, December 18). Interleukin-7 and T cells [Video file]. In The Biomedical & Life Sciences Collection, Henry Stewart Talks. Retrieved April 11, 2025, from https://doi.org/10.69645/KBVS6246.Export Citation (RIS)
Publication History
- Published on December 18, 2012
Financial Disclosures
- Dr. Scott Durum has not informed HSTalks of any commercial/financial relationship that it is appropriate to disclose.